Skip to main content
Erschienen in: Infection 2/2014

01.04.2014 | Clinical and Epidemiological Study

Epidemiology and risk factors for severe respiratory syncytial virus infections requiring pediatric intensive care admission in Hong Kong children

verfasst von: T. F. Leung, D. S. Y. Lam, T. Y. Miu, K. L. Hon, C. S. K. Chau, S. W. Ku, R. S. Y. Lee, P. Y. Chow, W. K. Chiu, D. K. K. Ng, on behalf of the Hong Kong Society of Paediatric Respirology (HKSPR) RSV Concern Group

Erschienen in: Infection | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Respiratory syncytial virus (RSV) is a common cause of lower respiratory tract infection in young children. However, there are limited data on severe RSV infection requiring pediatric intensive care unit (PICU) admission. This retrospective study described features of RSV-associated PICU admissions in Hong Kong and investigated factors for mortality and duration of PICU stay.

Methods

Children with laboratory-confirmed RSV infection and admitted to the PICUs of all eight government hospitals in Hong Kong between January 2009 and June 2011 were identified from computerized auditing systems and PICU databases. RSV in respiratory samples was detected by direct immunofluorescence and/or viral culture. The relationships between mortality and PICU duration and demographic and clinical factors were analyzed.

Results

A total of 118 (2.4 %) PICU admissions were identified among 4,912 RSV-positive pediatric cases in all hospitals. Sixty-five (55.6 %) patients were infants. PICU admissions were higher between October and March. Eight (6.8 %) patients died, but only two were infants. RSV-associated mortality was related to prior sick contact, presence of older siblings, neurodevelopmental conditions, chromosomal and genetic diseases, and bacterial co-infections, but none was significant following logistic regression analyses (odds ratio 9.36, 95 % confidence interval 0.91–96.03 for prior sick contact, p = 0.060). Chronic lung disease was the only risk factor for the duration of PICU admission (β = 0.218, p = 0.017).

Conclusions

The majority of RSV-infected children do not require PICU support. There is winter seasonality for RSV-associated PICU admission in Hong Kong. Prior sick contact is the only risk factor for RSV-associated mortality, whereas the presence of chronic lung disease is associated with longer PICU stay. The current risk-based approach of RSV prophylaxis may not be effective in reducing severe RSV infections.
Literatur
1.
Zurück zum Zitat Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O’Brien KL, Roca A, Wright PF, Bruce N, Chandran A, Theodoratou E, Sutanto A, Sedyaningsih ER, Ngama M, Munywoki PK, Kartasasmita C, Simões EA, Rudan I, Weber MW, Campbell H. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375:1545–55.PubMedCentralPubMedCrossRef Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O’Brien KL, Roca A, Wright PF, Bruce N, Chandran A, Theodoratou E, Sutanto A, Sedyaningsih ER, Ngama M, Munywoki PK, Kartasasmita C, Simões EA, Rudan I, Weber MW, Campbell H. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375:1545–55.PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Berger TM, Aebi C, Duppenthaler A, Stocker M; Swiss Pediatric Surveillance Unit. Prospective population-based study of RSV-related intermediate care and intensive care unit admissions in Switzerland over a 4-year period (2001–2005). Infection. 2009;37:109–16.PubMedCrossRef Berger TM, Aebi C, Duppenthaler A, Stocker M; Swiss Pediatric Surveillance Unit. Prospective population-based study of RSV-related intermediate care and intensive care unit admissions in Switzerland over a 4-year period (2001–2005). Infection. 2009;37:109–16.PubMedCrossRef
3.
Zurück zum Zitat Soilly AL, Ferdynus C, Desplanches O, Grimaldi M, Gouyon JB. Paediatric intensive care admissions for respiratory syncytial virus bronchiolitis in France: results of a retrospective survey and evaluation of the validity of a medical information system programme. Epidemiol Infect. 2012;140:608–16.PubMedCrossRef Soilly AL, Ferdynus C, Desplanches O, Grimaldi M, Gouyon JB. Paediatric intensive care admissions for respiratory syncytial virus bronchiolitis in France: results of a retrospective survey and evaluation of the validity of a medical information system programme. Epidemiol Infect. 2012;140:608–16.PubMedCrossRef
4.
Zurück zum Zitat Hon KL, Leung E, Tang J, Chow CM, Leung TF, Cheung KL, Ng PC. Premorbid factors and outcome associated with respiratory virus infections in a pediatric intensive care unit. Pediatr Pulmonol. 2008;43:275–80.PubMedCrossRef Hon KL, Leung E, Tang J, Chow CM, Leung TF, Cheung KL, Ng PC. Premorbid factors and outcome associated with respiratory virus infections in a pediatric intensive care unit. Pediatr Pulmonol. 2008;43:275–80.PubMedCrossRef
5.
Zurück zum Zitat Hon KL, Leung TF, Cheng WY, Ko NM, Tang WK, Wong WW, Yeung WH, Chan PK. Respiratory syncytial virus morbidity, premorbid factors, seasonality, and implications for prophylaxis. J Crit Care. 2012;27:464–8.PubMedCrossRef Hon KL, Leung TF, Cheng WY, Ko NM, Tang WK, Wong WW, Yeung WH, Chan PK. Respiratory syncytial virus morbidity, premorbid factors, seasonality, and implications for prophylaxis. J Crit Care. 2012;27:464–8.PubMedCrossRef
6.
Zurück zum Zitat Morris SK, Dzolganovski B, Beyene J, Sung L. A meta-analysis of the effect of antibody therapy for the prevention of severe respiratory syncytial virus infection. BMC Infect Dis. 2009;9:106.PubMedCentralPubMedCrossRef Morris SK, Dzolganovski B, Beyene J, Sung L. A meta-analysis of the effect of antibody therapy for the prevention of severe respiratory syncytial virus infection. BMC Infect Dis. 2009;9:106.PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat [No authors listed]. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998;102:531–7. CrossRef [No authors listed]. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998;102:531–7. CrossRef
8.
Zurück zum Zitat Lee JT, Chang LY, Wang LC, Kao CL, Shao PL, Lu CY, Lee PI, Chen JM, Lee CY, Huang LM. Epidemiology of respiratory syncytial virus infection in northern Taiwan, 2001–2005—seasonality, clinical characteristics, and disease burden. J Microbiol Immunol Infect. 2007;40:293–301.PubMed Lee JT, Chang LY, Wang LC, Kao CL, Shao PL, Lu CY, Lee PI, Chen JM, Lee CY, Huang LM. Epidemiology of respiratory syncytial virus infection in northern Taiwan, 2001–2005—seasonality, clinical characteristics, and disease burden. J Microbiol Immunol Infect. 2007;40:293–301.PubMed
9.
Zurück zum Zitat Thorburn K. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Arch Dis Child. 2009;94:99–103.PubMedCrossRef Thorburn K. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Arch Dis Child. 2009;94:99–103.PubMedCrossRef
10.
Zurück zum Zitat Medrano López C, García-Guereta L; CIVIC Study Group. Community-acquired respiratory infections in young children with congenital heart diseases in the palivizumab era: the Spanish 4-season civic epidemiologic study. Pediatr Infect Dis J. 2010;29:1077–82.PubMedCrossRef Medrano López C, García-Guereta L; CIVIC Study Group. Community-acquired respiratory infections in young children with congenital heart diseases in the palivizumab era: the Spanish 4-season civic epidemiologic study. Pediatr Infect Dis J. 2010;29:1077–82.PubMedCrossRef
11.
Zurück zum Zitat Ito H, Osamura T, Nakajima F, Fujiwara D, Kuwabara Y, Yamamoto T, Yasuno T, Komatsu H, Kizaki Z, Kishida K, Akiyama Y, Oomae T, Nakajima K, Nakamura A, Kiyosawa N, Nisikomori R. Survey of severe respiratory syncytial virus infection in Kyoto Prefecture from 2003 to 2007. Pediatr Int. 2010;52:273–8.PubMedCrossRef Ito H, Osamura T, Nakajima F, Fujiwara D, Kuwabara Y, Yamamoto T, Yasuno T, Komatsu H, Kizaki Z, Kishida K, Akiyama Y, Oomae T, Nakajima K, Nakamura A, Kiyosawa N, Nisikomori R. Survey of severe respiratory syncytial virus infection in Kyoto Prefecture from 2003 to 2007. Pediatr Int. 2010;52:273–8.PubMedCrossRef
12.
Zurück zum Zitat Papenburg J, Hamelin MÈ, Ouhoummane N, Carbonneau J, Ouakki M, Raymond F, Robitaille L, Corbeil J, Caouette G, Frenette L, De Serres G, Boivin G. Comparison of risk factors for human metapneumovirus and respiratory syncytial virus disease severity in young children. J Infect Dis. 2012;206:178–89.PubMedCrossRef Papenburg J, Hamelin MÈ, Ouhoummane N, Carbonneau J, Ouakki M, Raymond F, Robitaille L, Corbeil J, Caouette G, Frenette L, De Serres G, Boivin G. Comparison of risk factors for human metapneumovirus and respiratory syncytial virus disease severity in young children. J Infect Dis. 2012;206:178–89.PubMedCrossRef
13.
Zurück zum Zitat Purcell K, Fergie J. Driscoll Children’s Hospital respiratory syncytial virus database: risk factors, treatment and hospital course in 3308 infants and young children, 1991 to 2002. Pediatr Infect Dis J. 2004;23:418–23.PubMedCrossRef Purcell K, Fergie J. Driscoll Children’s Hospital respiratory syncytial virus database: risk factors, treatment and hospital course in 3308 infants and young children, 1991 to 2002. Pediatr Infect Dis J. 2004;23:418–23.PubMedCrossRef
14.
Zurück zum Zitat Buckingham SC, Quasney MW, Bush AJ, DeVincenzo JP. Respiratory syncytial virus infections in the pediatric intensive care unit: clinical characteristics and risk factors for adverse outcomes. Pediatr Crit Care Med. 2001;2:318–23.PubMedCrossRef Buckingham SC, Quasney MW, Bush AJ, DeVincenzo JP. Respiratory syncytial virus infections in the pediatric intensive care unit: clinical characteristics and risk factors for adverse outcomes. Pediatr Crit Care Med. 2001;2:318–23.PubMedCrossRef
15.
Zurück zum Zitat Wilkesmann A, Ammann RA, Schildgen O, Eis-Hübinger AM, Müller A, Seidenberg J, Stephan V, Rieger C, Herting E, Wygold T, Hornschuh F, Groothuis JR, Simon A; DSM RSV Ped Study Group. Hospitalized children with respiratory syncytial virus infection and neuromuscular impairment face an increased risk of a complicated course. Pediatr Infect Dis J. 2007;26:485–91.PubMedCrossRef Wilkesmann A, Ammann RA, Schildgen O, Eis-Hübinger AM, Müller A, Seidenberg J, Stephan V, Rieger C, Herting E, Wygold T, Hornschuh F, Groothuis JR, Simon A; DSM RSV Ped Study Group. Hospitalized children with respiratory syncytial virus infection and neuromuscular impairment face an increased risk of a complicated course. Pediatr Infect Dis J. 2007;26:485–91.PubMedCrossRef
16.
Zurück zum Zitat Zhang Q, Guo Z, Bai Z, MacDonald NE. A 4 year prospective study to determine risk factors for severe community acquired pneumonia in children in southern China. Pediatr Pulmonol. 2013;48:390–7.PubMedCrossRef Zhang Q, Guo Z, Bai Z, MacDonald NE. A 4 year prospective study to determine risk factors for severe community acquired pneumonia in children in southern China. Pediatr Pulmonol. 2013;48:390–7.PubMedCrossRef
17.
Zurück zum Zitat El Saleeby CM, Bush AJ, Harrison LM, Aitken JA, Devincenzo JP. Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children. J Infect Dis. 2011;204:996–1002.PubMedCentralPubMedCrossRef El Saleeby CM, Bush AJ, Harrison LM, Aitken JA, Devincenzo JP. Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children. J Infect Dis. 2011;204:996–1002.PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat DeVincenzo JP, El Saleeby CM, Bush AJ. Respiratory syncytial virus load predicts disease severity in previously healthy infants. J Infect Dis. 2005;191:1861–8.PubMedCrossRef DeVincenzo JP, El Saleeby CM, Bush AJ. Respiratory syncytial virus load predicts disease severity in previously healthy infants. J Infect Dis. 2005;191:1861–8.PubMedCrossRef
19.
Zurück zum Zitat American Academy of Pediatrics Committee on Infectious Diseases. Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics. 2009;124:1694–701.CrossRef American Academy of Pediatrics Committee on Infectious Diseases. Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics. 2009;124:1694–701.CrossRef
20.
Zurück zum Zitat Butt ML, Symington A, Janes M, Elliott L, Steele S, Paes BA. The impact of prophylaxis on paediatric intensive care unit admissions for RSV infection: a retrospective, single-centre study. Eur J Pediatr. 2011;170:907–13.PubMedCrossRef Butt ML, Symington A, Janes M, Elliott L, Steele S, Paes BA. The impact of prophylaxis on paediatric intensive care unit admissions for RSV infection: a retrospective, single-centre study. Eur J Pediatr. 2011;170:907–13.PubMedCrossRef
21.
Zurück zum Zitat Prais D, Danino D, Schonfeld T, Amir J. Impact of palivizumab on admission to the ICU for respiratory syncytial virus bronchiolitis: a national survey. Chest. 2005;128:2765–71.PubMedCrossRef Prais D, Danino D, Schonfeld T, Amir J. Impact of palivizumab on admission to the ICU for respiratory syncytial virus bronchiolitis: a national survey. Chest. 2005;128:2765–71.PubMedCrossRef
22.
Zurück zum Zitat Prais D, Schonfeld T, Amir J; Israeli Respiratory Syncytial Virus Monitoring Group. Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use. Pediatrics. 2003;112:548–52.PubMedCrossRef Prais D, Schonfeld T, Amir J; Israeli Respiratory Syncytial Virus Monitoring Group. Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use. Pediatrics. 2003;112:548–52.PubMedCrossRef
23.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC). Respiratory syncytial virus activity—United States, July 2007–December 2008. MMWR Morb Mortal Wkly Rep. 2008;57:1355–8. Centers for Disease Control and Prevention (CDC). Respiratory syncytial virus activity—United States, July 2007–December 2008. MMWR Morb Mortal Wkly Rep. 2008;57:1355–8.
24.
Zurück zum Zitat Khor CS, Sam IC, Hooi PS, Quek KF, Chan YF. Epidemiology and seasonality of respiratory viral infections in hospitalized children in Kuala Lumpur, Malaysia: a retrospective study of 27 years. BMC Pediatr. 2012;12:32.PubMedCentralPubMedCrossRef Khor CS, Sam IC, Hooi PS, Quek KF, Chan YF. Epidemiology and seasonality of respiratory viral infections in hospitalized children in Kuala Lumpur, Malaysia: a retrospective study of 27 years. BMC Pediatr. 2012;12:32.PubMedCentralPubMedCrossRef
25.
Zurück zum Zitat Kim CK, Choi J, Callaway Z, Kim HB, Chung JY, Koh YY, Shin BM. Clinical and epidemiological comparison of human metapneumovirus and respiratory syncytial virus in Seoul, Korea, 2003–2008. J Korean Med Sci. 2010;25:342–7.PubMedCentralPubMedCrossRef Kim CK, Choi J, Callaway Z, Kim HB, Chung JY, Koh YY, Shin BM. Clinical and epidemiological comparison of human metapneumovirus and respiratory syncytial virus in Seoul, Korea, 2003–2008. J Korean Med Sci. 2010;25:342–7.PubMedCentralPubMedCrossRef
26.
Zurück zum Zitat Broor S, Parveen S, Bharaj P, Prasad VS, Srinivasulu KN, Sumanth KM, Kapoor SK, Fowler K, Sullender WM. A prospective three-year cohort study of the epidemiology and virology of acute respiratory infections of children in rural India. PLoS One. 2007;2:e491.PubMedCentralPubMedCrossRef Broor S, Parveen S, Bharaj P, Prasad VS, Srinivasulu KN, Sumanth KM, Kapoor SK, Fowler K, Sullender WM. A prospective three-year cohort study of the epidemiology and virology of acute respiratory infections of children in rural India. PLoS One. 2007;2:e491.PubMedCentralPubMedCrossRef
27.
Zurück zum Zitat Sato M, Saito R, Sakai T, Sano Y, Nishikawa M, Sasaki A, Shobugawa Y, Gejyo F, Suzuki H. Molecular epidemiology of respiratory syncytial virus infections among children with acute respiratory symptoms in a community over three seasons. J Clin Microbiol. 2005;43:36–40.PubMedCentralPubMedCrossRef Sato M, Saito R, Sakai T, Sano Y, Nishikawa M, Sasaki A, Shobugawa Y, Gejyo F, Suzuki H. Molecular epidemiology of respiratory syncytial virus infections among children with acute respiratory symptoms in a community over three seasons. J Clin Microbiol. 2005;43:36–40.PubMedCentralPubMedCrossRef
28.
Zurück zum Zitat Suzuki A, Lupisan S, Furuse Y, Fuji N, Saito M, Tamaki R, Galang H, Sombrero L, Mondoy M, Aniceto R, Olveda R, Oshitani H. Respiratory viruses from hospitalized children with severe pneumonia in the Philippines. BMC Infect Dis. 2012;12:267.PubMedCentralPubMedCrossRef Suzuki A, Lupisan S, Furuse Y, Fuji N, Saito M, Tamaki R, Galang H, Sombrero L, Mondoy M, Aniceto R, Olveda R, Oshitani H. Respiratory viruses from hospitalized children with severe pneumonia in the Philippines. BMC Infect Dis. 2012;12:267.PubMedCentralPubMedCrossRef
29.
Zurück zum Zitat Leung TF, To MY, Yeung AC, Wong YS, Wong GW, Chan PK. Multiplex molecular detection of respiratory pathogens in children with asthma exacerbation. Chest. 2010;137:348–54.PubMedCrossRef Leung TF, To MY, Yeung AC, Wong YS, Wong GW, Chan PK. Multiplex molecular detection of respiratory pathogens in children with asthma exacerbation. Chest. 2010;137:348–54.PubMedCrossRef
30.
Zurück zum Zitat Lee W-M, Grindle K, Pappas T, Marshall DJ, Moser MJ, Beaty EL, Shult PA, Prudent JR, Gern JE. High-throughput, sensitive, and accurate multiplex PCR-microsphere flow cytometry system for large-scale comprehensive detection of respiratory viruses. J Clin Microbiol. 2007;45:2626–34.PubMedCentralPubMedCrossRef Lee W-M, Grindle K, Pappas T, Marshall DJ, Moser MJ, Beaty EL, Shult PA, Prudent JR, Gern JE. High-throughput, sensitive, and accurate multiplex PCR-microsphere flow cytometry system for large-scale comprehensive detection of respiratory viruses. J Clin Microbiol. 2007;45:2626–34.PubMedCentralPubMedCrossRef
31.
Zurück zum Zitat Leung TF, Li CY, Lam WY, Wong GW, Cheuk E, Ip M, Ng PC, Chan PK. Epidemiology and clinical presentations of human coronavirus NL63 infections in Hong Kong children. J Clin Microbiol. 2009;47:3486–92.PubMedCentralPubMedCrossRef Leung TF, Li CY, Lam WY, Wong GW, Cheuk E, Ip M, Ng PC, Chan PK. Epidemiology and clinical presentations of human coronavirus NL63 infections in Hong Kong children. J Clin Microbiol. 2009;47:3486–92.PubMedCentralPubMedCrossRef
32.
Zurück zum Zitat Peiris JS, Tang WH, Chan KH, Khong PL, Guan Y, Lau YL, Chiu SS. Children with respiratory disease associated with metapneumovirus in Hong Kong. Emerg Infect Dis. 2003;9:628–33.PubMedCentralPubMedCrossRef Peiris JS, Tang WH, Chan KH, Khong PL, Guan Y, Lau YL, Chiu SS. Children with respiratory disease associated with metapneumovirus in Hong Kong. Emerg Infect Dis. 2003;9:628–33.PubMedCentralPubMedCrossRef
33.
Zurück zum Zitat Mak RK, Tse LY, Lam WY, Wong GW, Chan PK, Leung TF. Clinical spectrum of human rhinovirus infections in hospitalized Hong Kong children. Pediatr Infect Dis J. 2011;30:749–53.PubMedCrossRef Mak RK, Tse LY, Lam WY, Wong GW, Chan PK, Leung TF. Clinical spectrum of human rhinovirus infections in hospitalized Hong Kong children. Pediatr Infect Dis J. 2011;30:749–53.PubMedCrossRef
Metadaten
Titel
Epidemiology and risk factors for severe respiratory syncytial virus infections requiring pediatric intensive care admission in Hong Kong children
verfasst von
T. F. Leung
D. S. Y. Lam
T. Y. Miu
K. L. Hon
C. S. K. Chau
S. W. Ku
R. S. Y. Lee
P. Y. Chow
W. K. Chiu
D. K. K. Ng
on behalf of the Hong Kong Society of Paediatric Respirology (HKSPR) RSV Concern Group
Publikationsdatum
01.04.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 2/2014
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-013-0557-1

Weitere Artikel der Ausgabe 2/2014

Infection 2/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.